Neuronetics, Inc. (STIM): Company Cash Volume

Official company branding of NeuroStar (STIM)

Neuronetics, Inc. (STIM) systems ensure a steady cash flow due to the regularity of therapy sessions. This cash reserve chart demonstrates current liquidity, with the 0.03 mark serving as the current balance indicator. However, slow technology adoption and competition from pharmaceuticals are weighing on margins. Simultaneously, Neuronetics, Inc. (STIM) is reducing production waste and energy costs in compliance with ESG environmental standards.

Company Cash Funds: Neuronetics, Inc (STIM) for 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for Neuronetics Inc. (STIM)

- stock quotes and analyst forecast:
- stock exchange capitalization data:
Initial company analysis:Neuronetics, Inc STIM
Brand item of Neuronetics

For the long-term investor, the financial stability of Neuronetics, Inc. (STIM) is determined by its ability to maintain liquidity amidst expansion. This metric captures the volume of available cash, allowing for an assessment of the company's net value and the elimination of hidden capital lock-up risks. The current cash balance stands at 0.03, reflecting the actual resources available for development. Global deliveries of equipment and software create a steady cash flow, guaranteeing the operational viability of the business.

Analysis of competing companies

Company Cash Volume BSX|Company Cash Funds EW (Edwards Lifesciences Corporation)|Company Cash Funds ResMed RMD|Company Cash Volume Insulet Corp PODD|ZBH: Company Cash on Hand|Company Cash Balance COO (CooperVision)|ALGN (Align Technology, Inc.) - Company Cash on Hand|Globus Medical, Inc. - Company Cash Balance|TMDX (TransMedics Group Inc) - Company Cash Volume|Company Cash Reserve Alphatec Holdings ATEC|Company Cash Funds CryoLife (AORT)|Enovis Corporation (ENOV) - Company Cash Position|Integra LifeSciences Inc. - Company Cash on Hand|Company Cash Volume Establishment Labs ESTA|Beta Bionics, Inc. - Company Cash Volume|Company Liquid Assets IRADIMED Corp IRMD|Embecta (EMBC) - Company Cash Funds|Company Total Cash Volume TNDM (Tandem Corp)|Company Cash Funds axogeninc.com|Company Cash on Hand SI-BONE, Inc. (SIBN)|Company Cash Volume OFIX|Bioventus Corp - Company Cash and Cash Equivalents|Company Cash Funds orthopediatrics.com KIDS|TMCI: Company Cash and Cash Equivalents|SRTA: Company Cash on Hand|Carlsmed Inc - Company Total Cash Amount|RxSight (RXST) - Company Cash Funds|Company Cash on Hand ClearPoint|Company Cash on Hand STXS|Sight Sciences, Inc (SGHT) - Company Liquid Assets|Company Cash Volume OBIO|Company Liquid Assets Anika Therapeutics Inc.|Company Cash Funds InspireMD, Inc. NSPR|Company Cash Balance ZJYL|VANI - Company Cash Funds|Xtant Medical Holdings, Inc. - Company Total Cash Amount|NeuroOne (NMTC) - Company Cash Funds|Modular Med (MODD) - Company Cash Volume|Company Cash Funds Myomo, Inc|Company Cash on Hand Envoy Medical (COCH)|Company Cash Volume VVOS|NVNO (enVVeno Corp) - Company Cash Balance|Company Cash Volume SINT (Sintx Technologies)|TNON: Company Cash and Cash Equivalents|Lifeward - Company Cash Volume|Company Cash Balance AMIX (Autonomix Medical)|IVF: Company Cash Volume|Company Cash Position Bone Biologics Corporation BBLG|Company Cash on Hand AXNX|BIOLASE, Inc. (BIOL) - Company Liquid Assets|Company Cash Volume DYNT|Company Liquid Assets Paragon 28|Company Cash Volume INVO (INVO Bioscience, Inc.)